Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Imatinib Mesylate
Imatinib Mesylate
Inquiry
| Post Date: | Aug 04,2014 |
| Expiry Date: | Jan 31,2015 |
| Detailed Description: | Cas No. :220127-57-1 In-house standard |
| CAS Registry Number: | 220127-57-1 |
| Synonyms: | ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form); |
| Molecular Formula: | C30H35N7O4S |
| Molecular Weight: | 589.71 |
| Molecular Structure: | 
|
| Company: | Lianyungang Guike Pharmaceutical Co.,ltd |
| Contact: | Sophia |
| Tel: | 0518-86070856 |
| Fax: | - |
| Email: | sophia@guikepharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
